While S&P 500 is at its all-time high, Danaher is still ~34% below its peak from late 2021. The company was beleaguered with ...

In this piece, we will look at the stocks Jim Cramer recently discussed.

In-Vitro Diagnostics Market 2025 IVD market set to grow at 5.0% CAGR to 2032, fueled by chronic disease demand, tech advances, and billion- ...

Contract research organizations are reporting better-than-expected second-quarter profit, a sign that Wall Street analysts ...

Acting Columbia president speaks out after $220 million settlement with Trump admin. CCTV Footage Captures the First-Ever ...

In a report released yesterday, Conor McNamara from RBC Capital maintained a Buy rating on Danaher, with a price target of $250.00. The company’s shares closed yesterday at $189.91. Take advantage of ...

In a report released today, Patrick B Donnelly from Citi maintained a Buy rating on Danaher, with a price target of $265.00. The company’s shares closed yesterday at $189.91. Take advantage of ...

Investors interested in Medical Services stocks are likely familiar with CVS Health (CVS) and Danaher (DHR). But which of these two stocks is more attractive to value investors? We'll need to take a ...

Danaher Corp soared in the stock market after announcing better-than-expected second-quarter results. The company reported ...

Union Pacific Corporation just upped its dividend game, announcing a 3% increase for Q3 2025, setting the new quarterly rate ...